Trans-ethnic genome-wide association study of severe COVID-19
暂无分享,去创建一个
Xihong Lin | Xin Jin | Chaolong Wang | Lei Liu | Fang Wang | Siyang Liu | X. Hao | Shanshan Cheng | Kezhen Li | Lin-lin Liu | H. Hou | Ziyong Sun | Huan Guo | Qing He | W. Ding | Peng Wu | Zilong Li | Ping Wu | Chaoyang Sun | Degang Wu | Fanjun Cheng | Xixiang Huo | Gang Chen | Kang Liu | Pinpin Long | Hao Wang | Yuhui Lin | Kai Wang | Wending Li | Qing Zhang | F. Zheng | Hui Gao | Wei Ni | Mingzhong Xiao | Yu Fu | T. Mo | Xiaodong Li | Qin Jiang | Gaokun Qiu | Yana Zhou | Xi Xu | Zuoyu Shao | Yan Jin | Xian Shi | Xuanwen Mu | Rong Peng | Panhong Liu | Jingzhi Wang | Jia Ke | Minghui Jiang | Limei Shi | Shi Han | Yingchun Zeng | Xuedan Xu | Lin Ding | Yu Yan | Minghan Qu | Z. Geng | Feng Wang | Xingjie Hao | D. Wu | Degang Wu | Yu Fu | Degang Wu | P. Long | Yu Fu | Hongyan Hou
[1] Mattia G. Bergomi,et al. Mapping the human genetic architecture of COVID-19 , 2021, Nature.
[2] Ruth I. Tennen,et al. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity , 2021, Nature Genetics.
[3] L. Bradley,et al. Lessons in antiviral immunity , 2021, Science.
[4] Huanming Yang,et al. Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility , 2020, Cell discovery.
[5] S. Pääbo,et al. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals , 2020, Nature.
[6] Barbara B. Shih,et al. Genetic mechanisms of critical illness in COVID-19 , 2020, Nature.
[7] Jacques Fellay,et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 , 2020, Science.
[8] S. Solomon,et al. Clinical Outcomes in Young US Adults Hospitalized With COVID-19. , 2020, JAMA internal medicine.
[9] A. Gylfason,et al. Humoral Immune Response to SARS-CoV-2 in Iceland , 2020, The New England journal of medicine.
[10] R. Rohs,et al. Landscape of DNA binding signatures of myocyte enhancer factor-2B reveals a unique interplay of base and shape readout , 2020, Nucleic acids research.
[11] U. Reimer,et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 , 2020, Nature.
[12] J. Schuurs-Hoeijmakers,et al. Presence of Genetic Variants Among Young Men With Severe COVID-19. , 2020, JAMA.
[13] Tangchun Wu,et al. Reconstruction of the full transmission dynamics of COVID-19 in Wuhan , 2020, Nature.
[14] Martin Linster,et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls , 2020, Nature.
[15] M. Hernán,et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study , 2020, The Lancet.
[16] Michael J. Purcaro,et al. Expanded encyclopaedias of DNA elements in the human and mouse genomes , 2020, Nature.
[17] C. Reed,et al. Seroprevalence of Antibodies to SARS-CoV-2 in Six Sites in the United States, March 23-May 3, 2020 , 2020, medRxiv.
[18] J. Erdmann,et al. Genomewide Association Study of Severe Covid-19 with Respiratory Failure , 2020, The New England journal of medicine.
[19] The COVID-19 Host Genetics Initiative. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic , 2020, European Journal of Human Genetics.
[20] M. He,et al. Lead exposure and its interactions with oxidative stress polymorphisms on lung function impairment: Results from a longitudinal population-based study. , 2020, Environmental research.
[21] Jian Chen,et al. Association between ABO blood groups and risk of SARS‐CoV‐2 pneumonia , 2020, British journal of haematology.
[22] Eun Ji Kim,et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.
[23] Jing Shi,et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan , 2020, Journal of Allergy and Clinical Immunology.
[24] Xihong Lin,et al. Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China. , 2020, JAMA.
[25] S. Merler,et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 2020, JAMA.
[26] Lei Liu,et al. Relationship between the ABO Blood Group and the COVID-19 Susceptibility , 2020, medRxiv.
[27] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[28] E. Dong,et al. An interactive web-based dashboard to track COVID-19 in real time , 2020, The Lancet Infectious Diseases.
[29] Hongbing Shen,et al. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations. , 2019, The Lancet. Respiratory medicine.
[30] Alicia R. Martin,et al. Clinical use of current polygenic risk scores may exacerbate health disparities , 2019, Nature Genetics.
[31] J. Casanova,et al. Lessons learned from the study of human inborn errors of innate immunity , 2019, The Journal of allergy and clinical immunology.
[32] D. Hinds,et al. Eleven loci with new reproducible genetic associations with allergic disease risk , 2019, The Journal of allergy and clinical immunology.
[33] Juan Burgueño,et al. Pilot genome-wide association study identifying novel risk loci for type 2 diabetes in a Maya population. , 2018, Gene.
[34] K. Basso,et al. MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis. , 2018, Cancer cell.
[35] Dennis Andersson,et al. A retrospective cohort study , 2018 .
[36] H. Teare,et al. Perceptions of legislation relating to the sharing of genomic biobank results with donors—a survey of BBMRI-ERIC biobanks , 2018, European Journal of Human Genetics.
[37] Doron Lancet,et al. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards , 2017, Database J. Biol. Databases Curation.
[38] T. Wieland,et al. Heterozygous HNRNPU variants cause early onset epilepsy and severe intellectual disability , 2017, Human Genetics.
[39] Jacob M. Luber,et al. HiGlass: web-based visual exploration and analysis of genome interaction maps , 2017, Genome Biology.
[40] Jessica A. Weber,et al. The Sentieon Genomics Tools – A fast and accurate solution to variant calling from next-generation sequence data , 2017, bioRxiv.
[41] J. Stoler,et al. Genetic and phenotypic dissection of 1q43q44 microdeletion syndrome and neurodevelopmental phenotypes associated with mutations in ZBTB18 and HNRNPU , 2017, Human Genetics.
[42] Alan M. Kwong,et al. Next-generation genotype imputation service and methods , 2016, Nature Genetics.
[43] Shane A. McCarthy,et al. Reference-based phasing using the Haplotype Reference Consortium panel , 2016, Nature Genetics.
[44] Anne W. Ndungu,et al. Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children , 2016, American journal of human genetics.
[45] H. Jäck,et al. Essential control of early B-cell development by Mef2 transcription factors. , 2016, Blood.
[46] Joseph K. Pickrell,et al. Detection and interpretation of shared genetic influences on 42 human traits , 2015, Nature Genetics.
[47] T. Jacques,et al. Human IFNAR2 deficiency: Lessons for antiviral immunity , 2015, Science Translational Medicine.
[48] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[49] Jun S. Liu,et al. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.
[50] Carson C Chow,et al. Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.
[51] Chaolong Wang,et al. Ancestry estimation and control of population stratification for sequence-based association studies , 2014, Nature Genetics.
[52] Hongbing Shen,et al. New loci associated with chronic hepatitis B virus infection in Han Chinese , 2013, Nature Genetics.
[53] F. Geissmann,et al. MEF2 Is an In Vivo Immune-Metabolic Switch , 2013, Cell.
[54] David C. Wilson,et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.
[55] Andre Franke,et al. Genome-wide association study indicates two novel resistance loci for severe malaria , 2012, Nature.
[56] Shanru Li,et al. Foxp4 Is Dispensable for T Cell Development, but Required for Robust Recall Responses , 2012, PloS one.
[57] M. Lu,et al. Foxp1/4 control epithelial cell fate during lung development and regeneration through regulation of anterior gradient 2 , 2012, Development.
[58] P. Bugert,et al. Blood Group ABO Genotyping in Paternity Testing , 2012, Transfusion Medicine and Hemotherapy.
[59] Eleazar Eskin,et al. Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. , 2011, American journal of human genetics.
[60] Josyf Mychaleckyj,et al. Robust relationship inference in genome-wide association studies , 2010, Bioinform..
[61] Michael Boehnke,et al. LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..
[62] Zhaoxia Yu,et al. Simultaneous genotype calling and haplotype phasing improves genotype accuracy and reduces false-positive associations for genome-wide association studies. , 2009, American journal of human genetics.
[63] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[64] E. Olson,et al. MEF2: a central regulator of diverse developmental programs , 2007, Development.
[65] Sonja W. Scholz,et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data , 2007, The Lancet Neurology.
[66] Sonja W. Scholz,et al. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data , 2006, The Lancet Neurology.
[67] B. Hansen,et al. Optimal Full Matching and Related Designs via Network Flows , 2006 .
[68] S. Goff,et al. Inhibition of HIV-1 gene expression by a fragment of hnRNP U. , 2006, Molecular cell.
[69] H. Whittle,et al. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[70] J. Sung,et al. ABO blood group and susceptibility to severe acute respiratory syndrome. , 2005, JAMA.
[71] Jun O. Liu,et al. Myocyte Enhancer Factor 2 Mediates Calcium-dependent Transcription of the Interleukin-2 Gene in T Lymphocytes , 2004, Journal of Biological Chemistry.
[72] Jun O. Liu,et al. Deletion of Calcineurin and Myocyte Enhancer Factor 2 (MEF2) Binding Domain of Cabin1 Results in Enhanced Cytokine Gene Expression in T Cells , 2001, The Journal of experimental medicine.
[73] Marc Parmentier,et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.
[74] David D. McDonald,et al. Programs , 1984, CL.